Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 13:19:56 UTC |
---|
Update Date | 2021-09-26 23:07:57 UTC |
---|
HMDB ID | HMDB0254146 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Lodoxamide |
---|
Description | Lodoxamide, also known as alomide or lodoxamide ethyl, belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. It is marketed under the tradename Alomide in the UK. Like cromoglicic acid it acts as a mast cell stabilizer. In 2014 lodoxamide and bufrolin were found to be potent agonists at the G protein-coupled receptor 35, an orphan receptor believed to play a role in inflammatory processes, pain and the development of stomach cancer. Lodoxamide is an extremely weak basic (essentially neutral) compound (based on its pKa). Lodoxamide is an antiallergic pharmaceutical drug. This compound has been identified in human blood as reported by (PMID: 31557052 ). Lodoxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Lodoxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N InChI=1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21) |
---|
Synonyms | Value | Source |
---|
Alomide | Kegg | Diethyl N,n'-(2-chloro-5-cyano-m-phenylene)dioxamate | MeSH | Lodoxamide ethyl | MeSH | {[3-(carboxyformamido)-2-chloro-5-cyanophenyl]carbamoyl}formate | Generator |
|
---|
Chemical Formula | C11H6ClN3O6 |
---|
Average Molecular Weight | 311.63 |
---|
Monoisotopic Molecular Weight | 310.9945126 |
---|
IUPAC Name | {[3-(carboxyformamido)-2-chloro-5-cyanophenyl]carbamoyl}formic acid |
---|
Traditional Name | lodoxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N |
---|
InChI Identifier | InChI=1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21) |
---|
InChI Key | RVGLGHVJXCETIO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid or derivatives
- Anilide
- Benzonitrile
- N-arylamide
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Dicarboxylic acid or derivatives
- Secondary carboxylic acid amide
- Carboxamide group
- Carboxylic acid
- Carbonitrile
- Nitrile
- Organochloride
- Organonitrogen compound
- Organic nitrogen compound
- Organooxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organohalogen compound
- Organic oxygen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Lodoxamide,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl | 2715.7 | Semi standard non polar | 33892256 | Lodoxamide,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl | 2583.0 | Standard non polar | 33892256 | Lodoxamide,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl | 3834.0 | Standard polar | 33892256 | Lodoxamide,3TMS,isomer #2 | C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C)=C1Cl)[Si](C)(C)C | 2608.5 | Semi standard non polar | 33892256 | Lodoxamide,3TMS,isomer #2 | C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C)=C1Cl)[Si](C)(C)C | 2584.2 | Standard non polar | 33892256 | Lodoxamide,3TMS,isomer #2 | C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C)=C1Cl)[Si](C)(C)C | 3682.2 | Standard polar | 33892256 | Lodoxamide,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl)[Si](C)(C)C | 2637.8 | Semi standard non polar | 33892256 | Lodoxamide,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl)[Si](C)(C)C | 2593.1 | Standard non polar | 33892256 | Lodoxamide,4TMS,isomer #1 | C[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C)[Si](C)(C)C)=C1Cl)[Si](C)(C)C | 3353.8 | Standard polar | 33892256 | Lodoxamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl | 3430.0 | Semi standard non polar | 33892256 | Lodoxamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl | 3201.7 | Standard non polar | 33892256 | Lodoxamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)NC1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl | 3886.5 | Standard polar | 33892256 | Lodoxamide,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C | 3332.3 | Semi standard non polar | 33892256 | Lodoxamide,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C | 3226.1 | Standard non polar | 33892256 | Lodoxamide,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C | 3776.9 | Standard polar | 33892256 | Lodoxamide,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C | 3507.8 | Semi standard non polar | 33892256 | Lodoxamide,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C | 3385.1 | Standard non polar | 33892256 | Lodoxamide,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)N(C1=CC(C#N)=CC(N(C(=O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C1Cl)[Si](C)(C)C(C)(C)C | 3625.8 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9381000000-89026fcdf0dbeae86f2f | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lodoxamide GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 10V, Positive-QTOF | splash10-03di-0019000000-c898c8550566f192349e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 20V, Positive-QTOF | splash10-03xr-2089000000-21ac75e7499c8701f432 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 40V, Positive-QTOF | splash10-00dl-6490000000-4876ae79df6c98fc5289 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 10V, Negative-QTOF | splash10-0a4i-1019000000-76594d6a809eef8750fc | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 20V, Negative-QTOF | splash10-0a4i-5069000000-4b022e277de6e3c246f5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 40V, Negative-QTOF | splash10-0006-9010000000-a23fd7c2e129e6aad422 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 10V, Positive-QTOF | splash10-03di-0029000000-f4c208cf9e3e785926b3 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 20V, Positive-QTOF | splash10-00xu-0491000000-fa4b34415c8eaf378b80 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 40V, Positive-QTOF | splash10-014i-0910000000-3dbe20b49441e13f83ea | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 10V, Negative-QTOF | splash10-01b9-0090000000-93f6e059a547d6fa5e0d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 20V, Negative-QTOF | splash10-014i-0090000000-7e6186f9901dd5eaaf08 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lodoxamide 40V, Negative-QTOF | splash10-01bc-1490000000-8c6feceaf5e252489120 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB06794 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Lodoxamide |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 44564 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|